Last Updated : November 6, 2019
Details
Generic Name:
lurasidone
Project Status:
Not filed
Therapeutic Area:
Bipolar I disorder
Manufacturer:
Sunovion Pharmaceuticals Inc.
Brand Name:
Latuda
Project Line:
Reimbursement Review
Project Number:
NS0010-000
Submission Type:
Non Submission
Fee Schedule:
N/A
Indications:
Bipolar I disorder
Recommendation Type:
Canada’s Drug Agency is unable to make a reimbursement recommendation as the manufacturer has not filed a submission.
Last Updated : November 6, 2019